Zobrazeno 1 - 10
of 219
pro vyhledávání: '"Thomas J Musholt"'
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-8 (2024)
Abstract Background Angiosarcoma of the adrenal gland is a very rare malignant vascular neoplasm. The clinical symptoms are atypical or completely absent. Angiosarcomas of the adrenal gland are therefore often discovered incidentally, and the diagnos
Externí odkaz:
https://doaj.org/article/f0b5eaddd14a4c5bbd7a0641a005e7b4
Autor:
Emilie Renaud, Kristina Riegel, Rossana Romero, Kushal Suryamohan, Ute Distler, Stefan Tenzer, Arno Schad, Thomas J. Musholt, Krishnaraj Rajalingam
Publikováno v:
Molecular Cancer, Vol 21, Iss 1, Pp 1-15 (2022)
Abstract Background Papillary thyroid carcinoma (PTC) is one of the most common forms of thyroid cancer with a cure rate of over 90% after surgery. However, aggressive forms may still occur, and personalized therapeutic strategies are increasingly re
Externí odkaz:
https://doaj.org/article/1704e3d8b4b446b596c5f38ff99f9ba3
Autor:
Thomas Eggermann, Miriam Elbracht, Ingo Kurth, Anders Juul, Trine Holm Johannsen, Irène Netchine, George Mastorakos, Gudmundur Johannsson, Thomas J. Musholt, Martin Zenker, Dirk Prawitt, Alberto M. Pereira, Olaf Hiort, on behalf of the European Reference Network on Rare Endocrine Conditions (ENDO-ERN
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-16 (2020)
Abstract Background With the development of molecular high-throughput assays (i.e. next generation sequencing), the knowledge on the contribution of genetic and epigenetic alterations to the etiology of inherited endocrine disorders has massively exp
Externí odkaz:
https://doaj.org/article/638f0e03cfd642ceb6f5dd7f9acab5fd
Autor:
Aswini Krishnan, Jean Berthelet, Emilie Renaud, Sebastian Rosigkeit, Ute Distler, Eric Stawiski, Jing Wang, Zora Modrusan, Marc Fiedler, Mariann Bienz, Stefan Tenzer, Arno Schad, Wilfried Roth, Bernd Thiede, Somasekar Seshagiri, Thomas J. Musholt, Krishnaraj Rajalingam
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-16 (2020)
Papillary thyroid cancer (PTC) is one of the most common type of endocrine malignancy. Here, the authors use proteogenomic approaches to analyse the primary tumour and lymph node metastases from a PTC patient and report an oncogenic RET fusion, and p
Externí odkaz:
https://doaj.org/article/d0a0473fc75243f2b229229426d6900d
Autor:
Daniel W. Kauff, MD, FEBS, Julia I. Staubitz, MD, Thomas J. Musholt, MD, FEBS, Hauke Lang, MD, FACS, MA
Publikováno v:
AACE Clinical Case Reports, Vol 4, Iss 1, Pp 21-25 (2018)
ABSTRACT: Objective: Antithyroid drugs (ATDs) such as thioimidazoles (e.g., methimazole, also called thiamazole, and carbimazole) and propylthiouracil are commonly used for the treatment of hyperthyroidism. A life-threatening reaction is agranulocyto
Externí odkaz:
https://doaj.org/article/09252d2f5c1041118d0cb24a9331891e
Publikováno v:
Endocrine Connections, Vol 7, Iss 1, Pp 47-55 (2017)
Poorly differentiated thyroid carcinoma (PDTC) is a rare malignancy with higher mortality than well-differentiated thyroid carcinoma. The histological diagnosis can be difficult as well as the therapy. Improved diagnosis and new targeted therapies re
Externí odkaz:
https://doaj.org/article/8899b1ae495d4406ab81b76df394dc5f
Autor:
Martina Ferrata, Arno Schad, Stefanie Zimmer, Thomas J. Musholt, Katharina Bahr, Julian Kuenzel, Sven Becker, Erik Springer, Wilfried Roth, Matthias M. Weber, Christian Fottner
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
The potential of neuroendocrine neoplasms (NEN) to respond to checkpoint inhibitors is largely unknown and full of great expectations. Immunohistochemical (IHC) studies of programmed cell death ligand 1 (PD-L1) expression in the tumor microenvironmen
Externí odkaz:
https://doaj.org/article/c1d0700d969c42d1a5de48438618a00c
Autor:
Julia I Staubitz, Celine Müller, Antonia Heymans, Christina Merten, Bianca Roos, Alicia Poplawski, Annekathrin Ludt, Stephanie Strobl, Erik Springer, Arno Schad, Wilfried Roth, Thomas J Musholt, Nils Hartmann
Publikováno v:
BJS Open. 7
Background Currently, treatment recommendations for papillary thyroid carcinoma are not based on the genetic background causing tumourigenesis. The aim of the present study was to correlate the mutational profile of papillary thyroid carcinoma with c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c94f12534f774be7ea07dbeb58f99f9b
https://doi.org/10.1093/bjsopen/zrad029
https://doi.org/10.1093/bjsopen/zrad029
Autor:
Julia I. Staubitz, Thomas J. Musholt
Publikováno v:
Die Chirurgie.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a44bf53eb96333d6c7d529d914ea512c
https://doi.org/10.1007/s00104-023-01878-x
https://doi.org/10.1007/s00104-023-01878-x
Autor:
Rick Schneider, Marcin Barczyński, Gayle E. Woodson, Allen S. Ho, Che-Wei Wu, Elizabeth Cottril, Thomas J. Musholt, Erin Buczek, Peter Angelos, Maria J. Téllez, Catherine F. Sinclair, Greg W. Randolph, V A Makarin, Neil Tolley, Brendan C. Stack, Joseph Scharpf
Publikováno v:
Head & Neck. 44:460-471
Background Intraoperative neuromonitoring (IONM) techniques have evolved over the past decade into intermittent IONM (I-IONM) and continuous IONM (C-IONM) modes of application. Despite many prior publications on both types of IONM, there remains unce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b4c3e7eac8c05028959733dc9d3246a
https://doi.org/10.1002/hed.26946
https://doi.org/10.1002/hed.26946